BMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity
- PMID: 40983272
- DOI: 10.1016/j.metabol.2025.156396
BMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity
Abstract
Contemporary lifestyle modifications such as changes in nutritional and sleep/wake rhythms increase the risk of metabolic and inflammatory complications linked to obesity, including type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH). BMAL2 (Brain and Muscle ARNT Like Protein 2) is a transcription factor belonging to the circadian clock transcriptional feedback loop which synchronizes internal biological rhythms to environment. In humans, reduced expression in white adipose tissue (WAT) and specific polymorphisms of BMAL2 are associated with obesity and T2D. In this study we report that Bmal2 deletion in mice leads to increased body weight gain during diet-induced obesity. Loss of BMAL2 triggers the inflammatory response by increasing Tnfα expression and modifying adipocyte progenitor fate. This results in reduced lipid storage capacity within the WAT and increased ectopic storage in the liver. These functional and structural alterations culminate in the onset of hepatic steatosis and insulin resistance in liver and WAT. Overall, our investigations underscore the role of BMAL2 in the development and function of adipocytes, as well as in their inflammatory potential within the WAT. Our findings contribute to the understanding of the role of circadian clock genes in obesity and interconnected metabolic complications.
Keywords: Adipose tissue; Circadian rhythm; Inflammation; Obesity; Preadipocytes.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Amine Toubal reports financial support was provided by French Association of Liver Research. Amine Toubal reports financial support was provided by Francophone Society for Diabetes. Amine Toubal reports financial support was provided by European Foundation for the Study of Diabetes. Agnes Lehuen reports financial support was provided by Laboratory of excellence Inflamex. Agnes Lehuen reports financial support was provided by Recherche Hospitalo-Universitaire (RHU) QUID-NASH program. Agnes Lehuen reports financial support was provided by French National Research Agency. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
